These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4211032)

  • 21. Carbon 13 nuclear magnetic resonance spectroscopy of myoglobins carboxymethylated with enriched (2- 13 C)bromoacetate.
    Nigen AM; Keim P; Marshall RC; Morrow JS; Vigna RA; Gurd FR
    J Biol Chem; 1973 May; 248(10):3724-32. PubMed ID: 4735715
    [No Abstract]   [Full Text] [Related]  

  • 22. Degradation of TRH and its analogues by rat serum and brain homogenate.
    Oliver C; Gillioz P; Giraud P; Conte-Devolx B
    Biochem Biophys Res Commun; 1978 Oct; 84(4):1097-102. PubMed ID: 103546
    [No Abstract]   [Full Text] [Related]  

  • 23. s-Cis and s-trans isomerism of the His-Pro peptide bond in angiotensin and thyroliberin analogues.
    Liakopoulou-Kyriakides M; Galardy RE
    Biochemistry; 1979 May; 18(10):1952-7. PubMed ID: 35219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic synthesis of thyrotropin releasing hormone (TRH) by hypothalamic "TRH synthetase".
    Mitnick M; Reichlin S
    Endocrinology; 1972 Nov; 91(5):1145-53. PubMed ID: 4627366
    [No Abstract]   [Full Text] [Related]  

  • 25. Structure and synthesis of the thyrotropin-releasing hormone.
    Enzmann F; Boler J; Folkers K; Bowers CY; Schally AV
    J Med Chem; 1971 Jun; 14(6):469-74. PubMed ID: 4997119
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthetic thyrotropin-releasing factor analogs. 3. Effect of replacement or modification of histidine residue on biological activity.
    Rivier J; Vale W; Monahan M; Ling N; Burgus R
    J Med Chem; 1972 May; 15(5):479-82. PubMed ID: 4624684
    [No Abstract]   [Full Text] [Related]  

  • 27. Conformational studies on the hypothalamic thyrotropin releasing factor and related compounds by 1-H nuclear magnetic resonance spectroscopy.
    Donzel B; Rivier J; Goodman M
    Biopolymers; 1974 Dec; 13(12):2631-47. PubMed ID: 4216375
    [No Abstract]   [Full Text] [Related]  

  • 28. Discovery of modification of the synthetic tripeptide-sequence of the thyrotropin releasing hormone having activity.
    Folkers K; Enzmann F; Boler J; Bowers CY; Schally AV
    Biochem Biophys Res Commun; 1969 Sep; 37(1):123-6. PubMed ID: 4981343
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessing the fractions of tautomeric forms of the imidazole ring of histidine in proteins as a function of pH.
    Vila JA; Arnautova YA; Vorobjev Y; Scheraga HA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5602-7. PubMed ID: 21422292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the role of the histidine moiety in the structure of the thyrotropin-releasing hormone.
    Sievertsson H; Chang JK; Folkers K; Bowers CY
    J Med Chem; 1972 Mar; 15(3):219-21. PubMed ID: 4621760
    [No Abstract]   [Full Text] [Related]  

  • 31. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide.
    Boler J; Enzmann F; Folkers K; Bowers CY; Schally AV
    Biochem Biophys Res Commun; 1969 Nov; 37(4):705-10. PubMed ID: 4982117
    [No Abstract]   [Full Text] [Related]  

  • 32. High-resolution proton NMR studies of low affinity hemoglobins.
    Shulman RG; Ogawa S; Mayer A; Castillo CL
    Ann N Y Acad Sci; 1973 Dec; 222():9-20. PubMed ID: 4522454
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
    Castensson S; Sievertsson H; Lindeke B; Sum CY
    FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of analogs of the thyrotropin-releasing hormone and structure-activity relationship.
    Chang JK; Sievertsson H; Currie B; Folkers K; Bowers C
    J Med Chem; 1971 Jun; 14(6):484-7. PubMed ID: 4997122
    [No Abstract]   [Full Text] [Related]  

  • 35. The assignment of an exchangeable low-field NH proton resonance of ribonuclease A to the active-site histidine-119.
    Griffin JH; Cohen JS; Schechter AN
    Biochemistry; 1973 May; 12(11):2096-9. PubMed ID: 4735881
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of rotational mobilities of backbone and side-chain carbons of poly(gamma-benzyl L-glutamate) in the helical and random-coil states from measurements of carbon-13 relaxation times and nuclear Overhauser enhancements.
    Allerhand A; Oldfield E
    Biochemistry; 1973 Aug; 12(18):3428-33. PubMed ID: 4731187
    [No Abstract]   [Full Text] [Related]  

  • 37. A nuclear magnetic resonance study of histidine-neodymium (3) complexes.
    Sherry AD; Birnbaum ER; Darnall DW
    J Biol Chem; 1972 Jun; 247(11):3489-94. PubMed ID: 5030628
    [No Abstract]   [Full Text] [Related]  

  • 38. Nuclear magnetic resonance titration curves of histidine ring protons. IV. The effects of phosphate and sulfate on ribonuclease.
    Cohen JS; Griffin JH; Schechter AN
    J Biol Chem; 1973 Jun; 248(12):4305-10. PubMed ID: 4736427
    [No Abstract]   [Full Text] [Related]  

  • 39. Structure of porcine thyrotropin releasing hormone.
    Nair RM; Barrett JF; Bowers CY; Schally AV
    Biochemistry; 1970 Mar; 9(5):1103-6. PubMed ID: 4984938
    [No Abstract]   [Full Text] [Related]  

  • 40. Biosynthesis of thyrotropin releasing factor by newt (Triturus viridescens) brain in vitro. Isolation and characterization of thyrotropin releasing factor.
    Grimm-Jorgensen Y; McKelvy JF
    J Neurochem; 1974 Sep; 23(3):471-8. PubMed ID: 4214528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.